The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Intelligent hearing systems sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Intelligent hearing systems is a medical equipment company that develops and manufactures products for the diagnosis and treatment of hearing and neurological disorders. The company offers innovative solutions for hearing and balance evaluation, using evoked potentials, otoacoustic emissions, hearing screeners, simulators, and audiometry techniques. Its product, SmartScreener-Plus 2 includes some tools to obtain statistical analysis of the infant hearing screenings that were performed, including passing rates, noise levels and individual screener performance. HIS also offers infant hearing screeners. The company provides products through a worldwide network of sales offices. IHS is headquartered in Miami, Florida, the US.
The key metrics of Intelligent hearing systems related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Intelligent hearing systems is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Intelligent hearing systems.
For a detailed understanding of the performance of Intelligent hearing systems, buy the report here.